U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07300228) titled 'Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers' on Dec. 10.
Brief Summary: The purpose of this clinical trial is to evaluate the efficacy and safety of Olistic Next Women, a nutraceutical supplement, in women diagnosed with early FPHL.This 6-month, open-label, interventional clinical trial investigates whether daily supplementation with Olistic Next Women leads to significant improvements in hair parameters. The study also monitors the tolerability and safety of the product throughout the intervention.
Study Start Date: Sept. 16, 2024
Study Type: INT...